Quality by design-assisted green uv-spectrophotometric method development and validation for the quantitative estimation of letrozole
DOI:
https://doi.org/10.22456/2527-2616.147251Keywords:
Quality by Design, Design of Experiment, UV-Spectrophotometry, Letrozole, Green Analytical ChemistryAbstract
Letrozole, a potent aromatase inhibitor, is commonly used in treating hormone-responsive breast cancer. With the rising incidence of breast cancer and increased demand for anticancer agents, this study aims to develop a green, cost-effective, and precise UV-spectrophotometric method for Letrozole estimation using Quality by Design (QbD) and Green Analytical Chemistry (GAC) approaches. A UV-spectrophotometric method was developed using an eco-friendly solvent system to improve the solubility and analytical efficiency of Letrozole. Method optimization was carried out using a QbD to ensure robustness and sustainability. The method was validated as per ICH Q2(R1) guidelines for linearity, accuracy, precision, specificity, and robustness, confirming its suitability for routine analysis. The developed method exhibited excellent linearity within the concentration range of 2–10 µg/mL, with a correlation coefficient (R²) of 0.9994. The limit of detection (LOD) and limit of quantification (LOQ) were determined to be 0.870 µg/mL and 2.021 µg/mL, respectively. Precision, robustness, and ruggedness assessments demonstrated percent relative standard deviation values below 2%, indicating high method reproducibility and reliability. The mean recovery values ranged from 99.71% to 102.40%, confirming the method’s accuracy. Furthermore, the assay of marketed formulations yielded consistent results, supporting the suitability of the method for routine quality control applications. A novel, simple, eco-friendly, and QbD guided UV-spectrophotometric method was successfully developed and validated for the estimation of Letrozole in bulk and pharmaceutical dosage forms. The method is suitable for routine analytical applications due to its precision, accuracy, and environmental sustainability.
Downloads
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834
Begum H, Sheikh K, Kumar M, Masood I, Khokhar A. International Cancer Burden Analysis 2020-2024: GLOBOCAN-Derived Estimates of Incidence and Mortality for 30 Malignancies in 190 Geographic Regions. Am J Biomed. 2025 Jan 1;13(1):1–18. DOI: https://doi.org/10.18081/2333-5106/2025.1/1
Waks AG, Winer EP. Breast cancer treatment: a review. Jama. 2019 Jan 22;321(3):288-300. DOI: https://doi.org/10.1001/jama.2018.19323
Nussbaumer S, Bonnabry P, Veuthey JL, Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta. 2011 Oct 15;85(5):2265-89. DOI: https://doi.org/10.1016/j.talanta.2011.08.034
Mondal N, Pal TK, Ghosal SK. Development and validation of a spectrophotometric method for estimation of letrozole in bulk and pharmaceutical formulation. Pharmazie. 2007 Aug 1;62(8):597-8.
Al-Shehri M, Hefnawy M, Abuelizz H, Alzamil A, Mohammed M, Alsaif N, et al. Development and validation of an UHPLC-MS/MS method for simultaneous determination of palbociclib, letrozole and its metabolite carbinol in rat plasma and pharmacokinetic study application. Arab J Chem. 2020 Feb 1;13(2):4024-34. DOI: https://doi.org/10.1016/j.arabjc.2019.05.005
Laha TK, Patnaik RK, Sen S. Reverse phase high performance liquid chromatographic method for the analysis of letrozole in pharmaceutical dosage forms. Indian J Pharm Sci. 2008 May;70(3):401. DOI: https://doi.org/10.4103/0250-474X.43019
Annapurna MM, Mohapatro C, Narendra A. Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations. J Pharm Anal. 2012 Aug 1;2(4):298-305. DOI: https://doi.org/10.1016/j.jpha.2012.01.010
El-Kosasy AM, Rahman MH, Abdelaal SH. Depression control in breast cancer patients: a new HPLC-UV method for the simultaneous determination of the co-administered drugs, letrozole and vilazodone, in human plasma. Int J Pharm Chem Biol Sci. 2018 Oct 1;8(4):319
Hegde AR, Padya BS, Soman S, Mutalik S. A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics. J Anal Sci Technol. 2021 Jun 11;12(1):25. DOI: https://doi.org/10.1186/s40543-021-00276-4
Acharjya SK, Bhattamisra SK, Muddana BR, Bera RV, Panda P, Panda BP, et al. Development of a high-performance liquid chromatographic method for determination of letrozole in wistar rat serum and its application in pharmacokinetic studies. Sci. Pharm. 2012 Aug 31;80(4):941. DOI: https://doi.org/10.3797/scipharm.1206-06
Sodeifian G, Sajadian SA. Solubility measurement and preparation of nanoparticles of an anticancer drug (Letrozole) using rapid expansion of supercritical solutions with solid cosolvent (RESS-SC). J Supercrit Fluids. 2018 Mar 1;133:239-52. DOI: https://doi.org/10.1016/j.supflu.2017.10.015
Hegde AR, Managuli RS, Naha A, Koteshwara KB, Reddy MS, Mutalik S. Full factorial experimental design for development and validation of a RP-HPLC method for estimation of letrozole in nanoformulations. Curr. Pharm. Anal. 2018 May 1;14(3):320-30. DOI: https://doi.org/10.2174/1573412913666171006152604
Mondal N, Pal TK, Ghosal SK. Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles. Acta Pol Pharm. 2009 Jan 1;66(1):11-7.
Priyadarsini S, Lahoti SR. Quality by design: optimization of letrozole solid lipid nanoparticle for breast cancer. Indian J Pharm Educ Res. 2022 Oct 1;56:1013-24. DOI: https://doi.org/10.5530/ijper.56.4.182
Priyadarsini S, Lahoti Sr. RP-HPLC method development and validation for quantification of letrozole solid lipid nanoparticle. J. Res. Pharm. 2022 Mar 1;26(2):421-30. DOI: https://doi.org/10.29228/jrp.139
Mondal N, Pal TK, Ghosal SK. Development and validation of a spectrophotometric method for estimation of letrozole in bulk and pharmaceutical formulation. Pharmazie. 2007 Aug 1;62(8):597-8.
Patil SM, Galatage ST, Patil AB. Development of validated UV spectrophotometric method for estimation of fosfestrol in bulk and pharmaceutical dosage form. World J Pharmaceutical Res. 2013 Aug 28;3(7):5541-8.
Acharjya SK, Mallick P, Panda P, Kumar KR, Annapurna MM. Spectrophotometric methods for the determination of letrozole in bulk and pharmaceutical dosage forms. J. Adv. Pharm. Technol. Res. 2010 Jul 1;1(3):348-53. DOI: https://doi.org/10.4103/0110-5558.72425
Ganesh M, Kamalakannan K, Patil R, Upadhyay S, Srivatsava A, Sivakumar T, et al. A validated UV spectrophotometric method for the determination of letrozole in bulk and solid dosage form. Rasyan J Chem. 2008 Jan;1:55-8.
Fukuda IM, Pinto CF, Moreira CD, Saviano AM, Lourenço FR. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz. J. Pharm. Sci. 2018 Nov 8;54:e01006. DOI: https://doi.org/10.1590/s2175-97902018000001006
Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE—Analytical GREEnness metric approach and software. Anal. Chem. 2020 Jun 15;92(14):10076-82. DOI: https://doi.org/10.1021/acs.analchem.0c01887
Bairagi A, Kothrukar R, Chikhale H, Kosanam S, Borse L. AQbD-novel strategy for analytical methods. Futur. J. Pharm. Sci. 2024 Oct 4;10(1):138. DOI: https://doi.org/10.1186/s43094-024-00706-1
Thorsteinsdóttir UA, Thorsteinsdóttir M. Design of experiments for development and optimization of a liquid chromatography coupled to tandem mass spectrometry bioanalytical assay. J. Mass Spectrom. 2021 Sep;56(9):e4727. DOI: https://doi.org/10.1002/jms.4727
Szpisják-Gulyás N, Al-Tayawi AN, Horváth ZH, László Z, Kertész S, Hodúr C. Methods for experimental design, central composite design and the Box–Behnken design, to optimise operational parameters: A review. Acta Aliment. 2023 Dec 4;52(4):521-37. DOI: https://doi.org/10.1556/066.2023.00235
Rao TN. Validation of analytical methods. Calibration and validation of analytical methods—a sampling of current approaches. 2018 Apr 25:131-41. DOI: https://doi.org/10.5772/intechopen.72087
Shabir GA, John Lough W, Arain SA, Bradshaw TK. Evaluation and application of best practice in analytical method validation. J. Liq. Chromatogr. Relat. Technol. 2007 Feb 1;30(3):311-33. DOI: https://doi.org/10.1080/10826070601084753
Yuwono M, Indrayanto G. Validation of chromatographic methods of analysis. Profiles of drug substances, excipients and related methodology. 2005 Jan 1;32:243-59. DOI: https://doi.org/10.1016/S0099-5428(05)32009-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
